Abstract
Taxol is an antitumor drug with cytotoxic properties that correlate with its microtubule-stabilizing activities. It has been reported that taxol parallels lipopolysaccharide in its effects on the induction of tumor necrosis factor-α (TNF-α) gene expression in macrophages (C. Bogdan and A. Ding, J. Leukocyte Biol., 52: 119–121, 1992; C. L. Manthey, M. E. Brandes, P. Y. Perera, and S. Vogel, J. Immunol., 149: 2459–2465, 1992; J. M. Carboni, C. Singh, and M. A. Tepper, Natl. Cancer Inst. Monogr., 15: 95–101, 1993). Structure-activity studies using taxol and related taxanes have been done to determine the relationship between the effects of taxol on TNF-α gene expression and its cytotoxic and microtubule-stabilizing activities. Using Northern blot analysis, it was found that changes in the structure of taxol that did not alter cytotoxicity did prevent the induction of TNF-α gene expression. The data presented in this paper demonstrate that the effects of taxol on TNF-α gene expression are distinct from its known cytotoxic properties.
Footnotes
-
↵1 This study was supported by USPHS Grants CA 39821 (S. B. H.), N511920, (J. W. B.), and CA 55139 (C. S. S.).
-
↵2 Supported by National Institute of General Medical Sciences Training Program in Pharmacological Sciences Grant 5T32GM07260.
-
↵3 To whom requests for reprints should be addressed, at Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461.
- Received August 8, 1994.
- Accepted September 26, 1994.
- ©1994 American Association for Cancer Research.